| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 10,838 | 30,719 | | Cost of Revenue | 2,112 | 1,901 | | | Gross Profit | 8,726 | 28,818 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 301 | 388 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 8,425 | 28,431 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (23,444) | (14,880) | | Earnings Before Interest And Taxes | 3,860 | 7,816 | | Interest Expense | 45 | 17 | | Income Before Tax | 3,816 | 7,800 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (15,063) | 13,534 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (15,063) | 13,534 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($15,063) | $13,534 |
|
0.63% Nasdaq 
0.03%
Income Statement
